Open Beta
TREN
MetriLume
TREN

US marketsLPCN

SEC-sourced researchBeta

LPCN

Lipocine Inc.

Company comparison ↗

Data passport

CIK
0001535955
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 1, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 11,198,144.0000 USD; December 2025: 1,976,677.0000 USD11.2M USD0 USD0December 2024December 2025
LPCN · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202411,198,144.0000Mar 10, 2026
December 20251,976,677.0000Mar 10, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20251,976,677.0000-9,627,505.0000-9,760,721.000017,005,612.00002,528,196.0000Mar 10, 2026
December 202411,198,144.00008,352.0000-1,221,233.000022,510,501.00001,512,936.0000Mar 10, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$1.98MDecember 2025Mar 10, 202610-K
Previous period revenueRevenues$11.2MDecember 2024Mar 10, 202610-K
Net incomeNetIncomeLoss-$9.63MDecember 2025Mar 10, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$9.76MDecember 2025Mar 10, 202610-K
Total assetsAssets$17.01MDecember 2025Mar 10, 202610-K
Total liabilitiesLiabilities$2.53MDecember 2025Mar 10, 202610-K

New filings

Explore methodology ↗